What is the correct way to manage anti-IgE treatment during the COVID-19 pandemic?
Anti-IgE treatment with omalizumab (or other biologics indicated for asthma) should be continued in non-infected patients. Self-administration devices at home, whenever this option is available, are preferred, to minimize face-to-face contact in the clinic. In infected patients, omalizumab administration should be delayed until complete clinical recovery and viral clearance is achieved.44,138